Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study

Background - Mothers with diabetes are less likely to achieve successful breastfeeding. Antenatal breastmilk expression (ABE) may facilitate earlier breastfeeding, but feasibility of introducing ABE and its acceptance among Scandinavian women have previously not been investigated. Methods - This obs...

Full description

Bibliographic Details
Published in:International Breastfeeding Journal
Main Authors: Johnsen, Maren, Klingenberg, Claus, Brand, Meta, Revhaug, Arthur, Andreassen, Gunnbjørg
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2021
Subjects:
Online Access:https://hdl.handle.net/10037/22620
https://doi.org/10.1186/s13006-021-00393-1
id ftunivtroemsoe:oai:munin.uit.no:10037/22620
record_format openpolar
spelling ftunivtroemsoe:oai:munin.uit.no:10037/22620 2023-05-15T18:34:53+02:00 Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study Johnsen, Maren Klingenberg, Claus Brand, Meta Revhaug, Arthur Andreassen, Gunnbjørg 2021-07-23 https://hdl.handle.net/10037/22620 https://doi.org/10.1186/s13006-021-00393-1 eng eng BMC International Breastfeeding Journal Johnsen, Klingenberg, Brand, Revhaug, Andreassen. Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study. International Breastfeeding Journal. 2021;16(1):1-6 FRIDAID 1924183 doi:10.1186/s13006-021-00393-1 1746-4358 https://hdl.handle.net/10037/22620 openAccess Copyright 2021 The Author(s) VDP::Medical disciplines: 700 VDP::Medisinske Fag: 700 Journal article Tidsskriftartikkel Peer reviewed publishedVersion 2021 ftunivtroemsoe https://doi.org/10.1186/s13006-021-00393-1 2021-09-29T22:53:54Z Background - Mothers with diabetes are less likely to achieve successful breastfeeding. Antenatal breastmilk expression (ABE) may facilitate earlier breastfeeding, but feasibility of introducing ABE and its acceptance among Scandinavian women have previously not been investigated. Methods - This observational trial was conducted between the 1 January 2019 and the 12 March 2020 in Tromsø, Norway. We aimed to determine the feasibility of ABE in terms of practicality and acceptability among women with medically (metformin or insulin) treated diabetes. Women were invited to participate during antenatal visits from 32 weeks gestation. Participants received instruction and started ABE from gestation week 37 + 0. Participants, and their infants, were followed until 6–8 weeks after birth. We collected data on breastfeeding rates, infant hypoglycemia, transfer to the neonatal unit, and the women’s overall experience and satisfaction with antenatal breastmilk expression. Results - Twenty-eight of 34 (82%) invited women consented to participate. All started ABE from week 37 + 0, and continued until hospital admission. No women reported any discomfort or side effects. Labor was induced at 38 weeks gestation. Twenty-four women brought harvested colostrum to the maternity ward, which was given to their infants during the first 24 h of life. Breastfeeding rates at discharge were 24/28 (86%) and 21/27 (78%) at 6–8 weeks after delivery. Seven (25%) infants were transferred to the neonatal unit; four because of hypoglycemia. Maternal satisfaction assessed 6–8 weeks after delivery revealed that all participants felt positive about the ABE, but one woman would not recommend it to other pregnant women. Conclusions - Implementing a structured ABE guideline for women with medically treated diabetes was feasible. The intervention was associated with high level of satisfaction among study participants. No obvious side effects were observed, and breastfeeding rates at discharge and 6–8 weeks after delivery were higher than in comparable studies. Article in Journal/Newspaper Tromsø University of Tromsø: Munin Open Research Archive Norway Tromsø International Breastfeeding Journal 16 1
institution Open Polar
collection University of Tromsø: Munin Open Research Archive
op_collection_id ftunivtroemsoe
language English
topic VDP::Medical disciplines: 700
VDP::Medisinske Fag: 700
spellingShingle VDP::Medical disciplines: 700
VDP::Medisinske Fag: 700
Johnsen, Maren
Klingenberg, Claus
Brand, Meta
Revhaug, Arthur
Andreassen, Gunnbjørg
Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study
topic_facet VDP::Medical disciplines: 700
VDP::Medisinske Fag: 700
description Background - Mothers with diabetes are less likely to achieve successful breastfeeding. Antenatal breastmilk expression (ABE) may facilitate earlier breastfeeding, but feasibility of introducing ABE and its acceptance among Scandinavian women have previously not been investigated. Methods - This observational trial was conducted between the 1 January 2019 and the 12 March 2020 in Tromsø, Norway. We aimed to determine the feasibility of ABE in terms of practicality and acceptability among women with medically (metformin or insulin) treated diabetes. Women were invited to participate during antenatal visits from 32 weeks gestation. Participants received instruction and started ABE from gestation week 37 + 0. Participants, and their infants, were followed until 6–8 weeks after birth. We collected data on breastfeeding rates, infant hypoglycemia, transfer to the neonatal unit, and the women’s overall experience and satisfaction with antenatal breastmilk expression. Results - Twenty-eight of 34 (82%) invited women consented to participate. All started ABE from week 37 + 0, and continued until hospital admission. No women reported any discomfort or side effects. Labor was induced at 38 weeks gestation. Twenty-four women brought harvested colostrum to the maternity ward, which was given to their infants during the first 24 h of life. Breastfeeding rates at discharge were 24/28 (86%) and 21/27 (78%) at 6–8 weeks after delivery. Seven (25%) infants were transferred to the neonatal unit; four because of hypoglycemia. Maternal satisfaction assessed 6–8 weeks after delivery revealed that all participants felt positive about the ABE, but one woman would not recommend it to other pregnant women. Conclusions - Implementing a structured ABE guideline for women with medically treated diabetes was feasible. The intervention was associated with high level of satisfaction among study participants. No obvious side effects were observed, and breastfeeding rates at discharge and 6–8 weeks after delivery were higher than in comparable studies.
format Article in Journal/Newspaper
author Johnsen, Maren
Klingenberg, Claus
Brand, Meta
Revhaug, Arthur
Andreassen, Gunnbjørg
author_facet Johnsen, Maren
Klingenberg, Claus
Brand, Meta
Revhaug, Arthur
Andreassen, Gunnbjørg
author_sort Johnsen, Maren
title Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study
title_short Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study
title_full Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study
title_fullStr Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study
title_full_unstemmed Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study
title_sort antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study
publisher BMC
publishDate 2021
url https://hdl.handle.net/10037/22620
https://doi.org/10.1186/s13006-021-00393-1
geographic Norway
Tromsø
geographic_facet Norway
Tromsø
genre Tromsø
genre_facet Tromsø
op_relation International Breastfeeding Journal
Johnsen, Klingenberg, Brand, Revhaug, Andreassen. Antenatal breastmilk expression for women with diabetes in pregnancy - a feasibility study. International Breastfeeding Journal. 2021;16(1):1-6
FRIDAID 1924183
doi:10.1186/s13006-021-00393-1
1746-4358
https://hdl.handle.net/10037/22620
op_rights openAccess
Copyright 2021 The Author(s)
op_doi https://doi.org/10.1186/s13006-021-00393-1
container_title International Breastfeeding Journal
container_volume 16
container_issue 1
_version_ 1766219852629934080